Monopar Therapeutics

Ownership Transactions Reported by 12 Insiders

Symbol
MNPR on Nasdaq
Location
1000 Skokie Blvd Suite 350, Wilmette, IL

Insiders trading volume in the past year

Monopar Therapeutics executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Arthur J. Klausner Director $1.05M Dec 31, 2023
Chandler Robinson Chief Executive Officer, Director $804K Sep 30, 2024
Andrew Cittadine Chief Operating Officer $278K +$100K +56.1% Sep 30, 2024
Michael J. Brown Director $137K Dec 31, 2023
Kim R. Tsuchimoto Chief Financial Officer, Director $96.4K Jun 30, 2024
Andrew Paul Mazar Chief Scientific Officer, Director $94.4K Mar 31, 2022
Christopher M. Starr Director $25.6K Dec 31, 2023
Karthik Radhakrishnan Chief Financial Officer $10.4K Oct 28, 2024
Raymond Anderson Director $9.14K Dec 31, 2023
TacticGem LLC 10%+ Owner $0 Dec 9, 2024
Patrice Rioux Acting Chief Medical Officer Jan 1, 2024
Jose Octavio Filho Chief Medical Officer Jul 12, 2021

Recent Insider Transactions by Companies or Individuals for Monopar Therapeutics

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.